Skip to main content Help with accessibility Skip to main navigation

TIOTROPIUM inhaler (Spiriva® Respimat®) in adults with asthma

CCG Approval Status:

Date Added: 01 - Nov - 2018
Body System:
Green

The Pan Mersey Area Prescribing Committee recommends the prescribing of TIOTROPIUM inhaler (Spiriva® Respimat®) as an option for patients with poorly controlled asthma who are already on a maintenance dose of inhaled corticosteroid plus a long-acting beta2 agonist inhaler.